Jefferies analyst Daniel Rizzo has maintained their bullish stance on ATR stock, giving a Buy rating today.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Daniel Rizzo has given his Buy rating due to a combination of factors that indicate AptarGroup’s potential for growth despite certain challenges. The company reported a strong Q4 performance, with earnings per share significantly exceeding expectations. This was driven by various segments, including closures and corporate, which showed positive contributions.
Looking forward, while there are near-term headwinds such as unfavorable foreign exchange rates and increased tax rates in France, AptarGroup’s long-term outlook remains promising. The destocking in nasal decongestants is expected to end soon, and new pharmaceutical products are anticipated to boost segment sales. Additionally, there is potential growth in the beauty segment, particularly in China and North America, and improvements in demand and margins in the closures segment. These factors contribute to a projected EBITDA growth and a strong compound annual growth rate through 2027, supporting the Buy rating.
In another report released today, Robert W. Baird also maintained a Buy rating on the stock with a $160.00 price target.
ATR’s price has also changed slightly for the past six months – from $143.600 to $143.180, which is a -0.29% drop .